Loading …

Algorae Pharmaceuticals (ASX: 1AI) is a capital-light pharmaceutical company operating AlgoraeRx, a commercial division sourcing and supplying generic and specialty medicines in Australia and New Zealand through Tier-1 global manufacturer agreements, and AlgoraeOS, an AI-enabled drug discovery platform validated at Peter MacCallum Cancer Centre. The Company is focused on near-term revenue through executed supply agreements and long-term pipeline value through its proprietary discovery engine.
Annual Revenue$1M to $5M
Estimated OwnershipPublicBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more